Fiche société
Herrick Medical LLC
Traitements, essais et publications liés.
Traitements3programmes
Essais2liés
Publications0liées
SourceDBlocale
Traitements
3| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| ECHS AD DeviceAn open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment. | Alzheimer | Non applicable | Ralentissement de la progression | United States | À vérifier |
| ECHS AD DeviceAn open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment. | Alzheimer | Non applicable | Ralentissement de la progression | United States | À vérifier |
| ECHS AD DeviceAn open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment. | Alzheimer | Non applicable | Ralentissement de la progression | United States | À vérifier |
Essais cliniques
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| ECHS AD Device | Alzheimer | Non applicable | NCT06862557 | Pulsed Electromagnetic Field Treatment With Dementia Patients | RECRUITING |
| ECHS AD Device | Alzheimer | Non applicable | NCT05295615 | Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease | RECRUITING |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||